Sort
82,697 grants matching “vaccine development”
Development of a novel adjuvant for vaccine sparing
$1,197,649Sara Lustigman · New York Blood Center · R01 · FY2015 · AI
Cell Prep Core
$1,197,564John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Cell Production Facility Core
$1,197,564Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,197,237Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,197,237Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
BSL4 Evaluation Core
$1,197,196Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2016 · AI
Development of Small Molecule Therapeutics Against Smallpox and Other Poxviruses
$1,197,020Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2016 · AI
Immune Function and Biodefense in Children, Elderly, and the Immunocrompromised
$1,197,000Jack Gorski · Versiti Wisconsin, Inc. · N01 · FY2009 · AI
New Strategies to Prevent Death from Influenza
$1,196,788Kendall A Smith · Weill Medical Coll Of Cornell Univ · U01 · FY2010 · AI
Clinical and Informatics Research on Large Clinical Databases
$1,196,486Clement McDonald · National Library Of Medicine · ZIA · FY2025 · LM
The "Dynamics of the immune responses to repeat influenza vaccination exposures" (DRIVE) Study
$1,196,470Sarah Cobey · University Of Chicago · U01 · FY2020 · AI
Laboratory And Preclinical Studies Of Flaviviruses
$1,196,438Stephen Whitehead · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,196,407Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Virome and Immune Responses associated with IA and Type 1 Diabetes
$1,195,882Richard E Lloyd · Baylor College Of Medicine · R01 · FY2024 · DK
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,195,794Mark Connors · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
ANTI-VIRAL IMMUNE MECHANISMS IN EARLY CHILDHOOD
$1,195,461Stanford University · P01 · FY2002 · AI
Clinical Evaluation of Novel Adenovirus Vectors
$1,195,436Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI
Localized mHealth approach to boosting COVID-19 testing and vaccine literacy, access, and uptake among women with criminal legal system involvement
$1,195,191Jason Edwin Glenn · University Of Kansas Medical Center · U01 · FY2023 · MD
Preclinical development of a chimeric tetravalent dengue vaccine
$1,195,165Dan Thomas Stinchcomb · Inviragen, Inc. · U01 · FY2007 · AI
SDMC: HPTN 084 Pregnancy Supplement
$1,195,111Deborah J Donnell · Fred Hutchinson Cancer Center · UM1 · FY2024 · AI
Host-pathogen interactions in experimental cholera
$1,195,060Matthew K Waldor · Brigham And Women'S Hospital · R01 · FY2025 · AI
Machine Learning to Modulate Influenza Immunity
$1,195,056Jens Meiler · Vanderbilt University · U01 · FY2025 · AI
Closing Research Gaps in Antiretroviral Treatment for Pregnant Women and Infants Living with HIV
$1,195,048Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2024 · HD
Structural characterization of OM proteins from Gram-negative pathogens
$1,194,758Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Evaluating timing and extent of prenatal exposure to dolutegravir and early childhood outcomes
$1,194,553Jillian Pintye · University Of Washington · P01 · FY2022 · HD